Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Frank Misselwitz

Frank Misselwitz publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology, on topics such as Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management and Antiplatelet Therapy and Cardiovascular Diseases.

ORCID 0000-0003-1366-7958 OpenAlex
World rank
#197,812
of 7,710,434 ranked researchers
Rank in Germany
#10,053
of 364,343
Works
168
Citations
17k
Citations per work
99.4
h-index
46
i10-index 84Top 3.8% in Cardiology and Cardiovascular Medicine
Frank Misselwitz

What does Frank Misselwitz research?

Frank Misselwitz's work is mostly in Medicine (74%), Economics, Econometrics and Finance (5%).

Health Sciences: 123 works · 73.5% of their workMedicine: 123 works · 73.5% of their workCardiology and Cardiovascular Medicine: 68 works · 40.6% of their workInternal Medicine: 29 works · 17.5% of their workHematology: 12 works · 7.0% of their workSurgery: 10 works · 5.9% of their workPulmonary and Respiratory Medicine: 4 works · 2.5% of their workEverything else: 36 works · 21.5% of their workSocial Sciences: 8 works · 5.0% of their workEconomics, Econometrics and Finance: 8 works · 5.0% of their workEconomics and Econometrics: 8 works · 5.0% of their workTHEIR WORKFrank Misselwitz168works
Health Sciences74%Social Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12373.5%
  2. Everything else3621.5%
    1. Economics, Econometrics and Finance85.0%
  1. 1Cardiology and Cardiovascular Medicine41% of their works
  2. 2Internal Medicine18% of their works
  3. 3Hematology7% of their works
  4. 4Surgery6% of their works
  5. 5Economics and Econometrics5% of their works
  6. 6Pulmonary and Respiratory Medicine2% of their works

Research topics

Which keywords describe Frank Misselwitz's research?

The keywords of their largest research topics: Guidelines, Anticoagulant Therapy, Atrial Fibrillation, Antithrombotic Therapy, Diagnosis, Pulmonary Embolism, Venous Thromboembolism and Aspirin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Guidelines1162 topics
  2. Anticoagulant Therapy1041 topic
  3. Atrial Fibrillation1041 topic
  4. Antithrombotic Therapy932 topics
  5. Diagnosis882 topics
  6. Pulmonary Embolism771 topic
  7. Venous Thromboembolism771 topic
  8. Aspirin361 topic
  9. Clopidogrel361 topic
  10. Hemostasis262 topics
  11. Inflammation262 topics
  12. Thrombosis212 topics
  13. Protease-Activated Receptors161 topic
  14. Thrombin161 topic
  15. Cost-effectiveness Analysis151 topic
  16. Quality of Life151 topic
  17. Acute Coronary Syndromes121 topic
  18. Myocardial Infarction121 topic
  19. Heparin-Induced Thrombocytopenia111 topic
  20. Vaccination111 topic
  21. Immune Thrombocytopenic Purpura101 topic
  22. Platelets101 topic

Where does Frank Misselwitz work?

Frank Misselwitz's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Frank Misselwitz have?

OpenAlex counts 168 works and 16,699 citations for Frank Misselwitz, an h-index of 46, ranking #197,812 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Frank Misselwitz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.